Pidotimod
CAS No. 121808-62-6
Pidotimod( PGT/1A )
Catalog No. M10818 CAS No. 121808-62-6
Pidotimod is an immunostimulant.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 29 | In Stock |
|
| 100MG | 28 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | 45 | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NamePidotimod
-
NoteResearch use only, not for human use.
-
Brief DescriptionPidotimod is an immunostimulant.
-
DescriptionPidotimod is an immunostimulant.(In Vivo):In toxicology study in animals, Pidotimod (oral gavage; 800 mg/kg;12 months) is non-toxic in rats and is non-toxic dogs at 600 mg/kg. Pidotimod is non-teratogenic in rats (600 mg/kg orally or 1000 mg/kg IV) and has no effects on subsequent embryofoetal development in rats (up to 1000 mg/kg/day),it has no perinatal or postnatal toxic effects in rats (600 mg/kg orally).In ex vivo experiments in mice, Pidotimod (intraperitoneal administration; 200 mg/kg; 5 days) potentiats natural killer (NK) cell activity and produces an increase in the proliferative response to mitogens such as concanavalin A (ConA) and interleukin-2 (IL-2).Pidotimod (intraperitoneal administration; 10-100 mg/kg) normalizes depletion of peritoneal macrophage numbers, and significantly increases macrophage superoxide anion (O2–) production in methylprednisolone-induced immunosuppressed mice.
-
In Vitro——
-
In VivoIn toxicology study in animals, Pidotimod (oral gavage; 800 mg/kg;12 months) is non-toxic in rats and is non-toxic dogs at 600 mg/kg. Pidotimod is non-teratogenic in rats (600 mg/kg orally or 1000 mg/kg IV) and has no effects on subsequent embryofoetal development in rats (up to 1000 mg/kg/day),it has no perinatal or postnatal toxic effects in rats (600 mg/kg orally).In ex vivo experiments in mice, Pidotimod (intraperitoneal administration; 200 mg/kg; 5 days) potentiats natural killer (NK) cell activity and produces an increase in the proliferative response to mitogens such as concanavalin A (ConA) and interleukin-2 (IL-2). Pidotimod (intraperitoneal administration; 10-100 mg/kg) normalizes depletion of peritoneal macrophage numbers, and significantly increases macrophage superoxide anion (O2–) production in methylprednisolone-induced immunosuppressed mice.
-
SynonymsPGT/1A
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research AreaInflammation/Immunology
-
Indication——
Chemical Information
-
CAS Number121808-62-6
-
Formula Weight244.27
-
Molecular FormulaC9H12N2O4S
-
Purity>98% (HPLC)
-
SolubilityWater: 10 mg/mL (40.93 mM); DMSO: 49 mg/mL (200.59 mM)
-
SMILESO=C([C@H]1N(C([C@H](CC2)NC2=O)=O)CSC1)O
-
Chemical Name(R)-3-((S)-5-Oxopyrrolidine-2-carbonyl)thiazolidine-4-carboxylic acid
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Clemente E, et al. Arzneimittelforschung, 1994, 44(12A), 1490-1494.
molnova catalog
related products
-
Taxezopidine H
The heartwoods of Taxus cuspidata.
-
Lithium acetoacetate
Acetoacetic acid (AcAc) is a weak organic acid that can be produced in the human liver under certain conditions of poor metabolism leading to excessive fatty acid breakdown (diabetes mellitus leading to diabetic ketoacidosis).
-
Terrestrosin D
Terrestrosin D can induce apoptotic cell death and inhibit angiogenesis in xenograft tumor cells, cell cycle arrest and induction of apoptosis in cancer cells and endothelial cells might be plausible mechanisms of actions for the observed antitumor and antiangiogenic activities of terrestrosin D.
Cart
sales@molnova.com